The Insights newsletter highlights the clinical and research accomplishments of the division. We'll also share details of Children's Cancer Hospital activities, and employees and faculty accolades.
Advances in Pediatric Cellular Therapy Options
The Advances in Pediatric Stem Cell Transplantation and Cellular Therapy quarterly newsletter highlights new therapeutic studies that are available to patients--some as young as 12-months-old--with cancer. Many of these therapies are unique to MD Anderson. Some treatment options inlcude regenerative medicine.
February 2021: Phase II clinical trial for examining stem cell transplantation in sarcoma/solid tumor patients
September 2020: Umbilical cord-derived CAR-engineered natural killer (NK) cell trial for lymphoid cancers
Children's Cancer Hospital Fiscal Year 2022 Year in Review
This report summarizes accomplishments in our clinical, research, education, administrative and support programs in the past year.